Corpus Intelligence IC Memo — HCA FLORIDA ST. LUCIE HOSPITAL 2026-04-26 08:04 UTC
IC Memo — HCA FLORIDA ST. LUCIE HOSPITAL
Investment Committee Memorandum | FL | 207 beds | Grade B | EBITDA uplift $19.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA ST. LUCIE HOSPITAL

CCN 100260 | ST. LUCIE, FL | 207 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA ST. LUCIE HOSPITAL is a 207-bed suburban community hospital in ST. LUCIE, FL with $265.1M in net patient revenue and a 47.0% operating margin. The hospital serves a payer mix of 29.9% Medicare, 8.8% Medicaid, and 61.2% commercial.

Thesis: Platform Growth. Our ML models identify $19.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 47.0% to 54.4% (+736bps).

Net Revenue HCRIS$265.1M
Current EBITDA COMPUTED$124.7M
Operating Margin COMPUTED47.0%
Occupancy HCRIS72.6%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS10.6%
Distress Probability ML42.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
122
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 47.0% places it above the state median. Among 122 size-comparable peers (104-414 beds), the median margin is 3.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (104-414), prioritizing same-state peers. 122 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA ST. LUCIE HOSPITAL (Target)FL207$265.1M47.0%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
SOUTH MIAMI HOSPITALFL375$688.4M11.6%
BOCA RATON REGIONAL HOSPITALFL361$609.5M-9.6%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.6M+210bp18mo
Cost to Collect4.5%2.5%$5.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.2M+122bp9mo
Clean Claim Rate88.0%96.0%$170K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.6M
Cost to Collect
$5.3M
Denial Rate Reduction
$5.2M
A/R Days Reduction
$3.2M
Clean Claim Rate
$170K
Total EBITDA Uplift$19.5M
Current EBITDA$124.7M
+ RCM Uplift+$19.5M
Pro Forma EBITDA$144.2M
Current Margin47.0%
Pro Forma Margin54.4%
WC Released (1x)$10.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$191.9M$1.02B5.30x39.6%
Base (11x exit)10.0x11.0x$191.9M$1.18B6.16x43.9%
Bull Case9.0x11.0x$172.7M$1.31B7.58x49.9%
Bull (12x exit)9.0x12.0x$172.7M$1.48B8.56x53.6%
Bear Case11.0x10.0x$211.1M$857.9M4.06x32.4%
Bear (11x exit)11.0x11.0x$211.1M$1.01B4.80x36.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 122 hospitals with 104-414 beds
  • Same-state prioritization (n=123)
  • Comp margins: P25=-6.2% / P50=3.2% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.